Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Jul;52(7):531–533. doi: 10.1136/ard.52.7.531

Scleroderma and malignancy: an epidemiological study.

A K Rosenthal 1, J K McLaughlin 1, M S Linet 1, I Persson 1
PMCID: PMC1005093  PMID: 8346981

Abstract

OBJECTIVES--Although case reports and some patient series suggest an increased risk of cancer among patients with scleroderma, there are no population based studies to support this association. A population based follow up study was therefore carried out of 233 patients with scleroderma from the six-county Uppsala health care region of Sweden for the time period 1955-84. METHODS--Using the inpatient registry for the Uppsala health care region, all patients with scleroderma were identified. Their unique identification codes were then used to perform a record linkage with the National Cancer Registry. Expected cancer rates were determined using the age and gender specific rates for the Uppsala health care region. RESULTS--The standardised incidence ratio (SIR) for all cancers among these patients was significantly increased (SIR = 2.4; 95% CI = 1.5 to 3.6). The SIRs for lung cancer (SIR = 7.8; 95% CI = 2.5 to 18.2) and non-Hodgkin's lymphoma (SIR = 9.6; 95% CI = 1.1 to 34.5) were also significantly increased. Excluding patients who were diagnosed with cancer within a year of their scleroderma diagnosis resulted in similar findings, though the SIR for non-Hodgkin's lymphoma was no longer statistically significant. CONCLUSIONS--Larger population based investigations of cancer risk among patients with scleroderma are needed to confirm these initial findings and to evaluate in greater detail possible cancer risk among these patients.

Full text

PDF
531

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami H. O., McLaughlin J., Ekbom A., Berne C., Silverman D., Hacker D., Persson I. Cancer risk in patients with diabetes mellitus. Cancer Causes Control. 1991 Sep;2(5):307–314. doi: 10.1007/BF00051670. [DOI] [PubMed] [Google Scholar]
  2. Allen-Hoffmann B. L., Crankshaw C. L., Mosher D. F. Transforming growth factor beta increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts. Mol Cell Biol. 1988 Oct;8(10):4234–4242. doi: 10.1128/mcb.8.10.4234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Black K. A., Zilko P. J., Dawkins R. L., Armstrong B. K., Mastaglia G. L. Cancer in connective tissue disease. Arthritis Rheum. 1982 Sep;25(9):1130–1133. doi: 10.1002/art.1780250916. [DOI] [PubMed] [Google Scholar]
  4. Cartwright R. A., McKinney P. A., O'Brien C., Richards I. D., Roberts B., Lauder I., Darwin C. M., Bernard S. M., Bird C. C. Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire. Leuk Res. 1988;12(1):81–88. doi: 10.1016/s0145-2126(98)80012-x. [DOI] [PubMed] [Google Scholar]
  5. D'Angelo W. A., Fries J. F., Masi A. T., Shulman L. E. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969 Mar;46(3):428–440. doi: 10.1016/0002-9343(69)90044-8. [DOI] [PubMed] [Google Scholar]
  6. Doyle J. A., Connolly S. M., Hoagland H. C. Hematologic disease in scleroderma syndromes. Acta Derm Venereol. 1985;65(6):521–525. [PubMed] [Google Scholar]
  7. Duncan S. C., Winkelmann R. K. Cancer and scleroderma. Arch Dermatol. 1979 Aug;115(8):950–955. [PubMed] [Google Scholar]
  8. Franceschi S., Serraino D., Bidoli E., Talamini R., Tirelli U., Carbone A., La Vecchia C. The epidemiology of non-Hodgkin's lymphoma in the north-east of Italy: a hospital-based case-control study. Leuk Res. 1989;13(6):465–472. doi: 10.1016/0145-2126(89)90168-9. [DOI] [PubMed] [Google Scholar]
  9. Hakulinen T., Isomaki H., Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med. 1985 Jan 21;78(1A):29–32. doi: 10.1016/0002-9343(85)90242-6. [DOI] [PubMed] [Google Scholar]
  10. Kassan S. S., Thomas T. L., Moutsopoulos H. M., Hoover R., Kimberly R. P., Budman D. R., Costa J., Decker J. L., Chused T. M. Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978 Dec;89(6):888–892. doi: 10.7326/0003-4819-89-6-888. [DOI] [PubMed] [Google Scholar]
  11. Katzka D. A., Reynolds J. C., Saul S. H., Plotkin A., Lang C. A., Ouyang A., Jimenez S., Cohen S. Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med. 1987 Jan;82(1):46–52. doi: 10.1016/0002-9343(87)90376-7. [DOI] [PubMed] [Google Scholar]
  12. Lee P., Alderdice C., Wilkinson S., Keystone E. C., Urowitz M. B., Gladman D. D. Malignancy in progressive systemic sclerosis--association with breast carcinoma. J Rheumatol. 1983 Aug;10(4):665–666. [PubMed] [Google Scholar]
  13. Leroy E. C., Smith E. A., Kahaleh M. B., Trojanowska M., Silver R. M. A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer? Arthritis Rheum. 1989 Jul;32(7):817–825. [PubMed] [Google Scholar]
  14. Medsger T. A., Jr Systemic sclerosis and malignancy--are they related? J Rheumatol. 1985 Dec;12(6):1041–1043. [PubMed] [Google Scholar]
  15. Naessén T., Parker R., Persson I., Zack M., Adami H. O. Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Am J Epidemiol. 1989 Aug;130(2):289–299. doi: 10.1093/oxfordjournals.aje.a115335. [DOI] [PubMed] [Google Scholar]
  16. Okayasu I., Mizutani H., Kurihara H., Yanagisawa F. Cancer in collagen disease. A statistical analysis by reviewing the Annual of Pathological Autopsy Cases (Nippon Boken Shuho) in Japan. Cancer. 1984 Nov 1;54(9):1841–1844. doi: 10.1002/1097-0142(19841101)54:9<1841::aid-cncr2820540912>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  17. PIPER W. N., HELWIG E. B. Progressive systemic sclerosis; visceral manifestations in generalized scleroderma. AMA Arch Derm. 1955 Dec;72(6):535–546. doi: 10.1001/archderm.1955.03730360041004. [DOI] [PubMed] [Google Scholar]
  18. Pearce N., Porta M. Association of non-Hodgkin's lymphoma with rheumatoid arthritis. Am J Med. 1986 Oct;81(4):747–748. doi: 10.1016/0002-9343(86)90573-5. [DOI] [PubMed] [Google Scholar]
  19. Peters-Golden M., Wise R. A., Hochberg M., Stevens M. B., Wigley F. M. Incidence of lung cancer in systemic sclerosis. J Rheumatol. 1985 Dec;12(6):1136–1139. [PubMed] [Google Scholar]
  20. Pinczowski D., McLaughlin J. K., Läckgren G., Adami H. O., Persson I. Occurrence of testicular cancer in patients operated on for cryptorchidism and inguinal hernia. J Urol. 1991 Nov;146(5):1291–1294. doi: 10.1016/s0022-5347(17)38071-0. [DOI] [PubMed] [Google Scholar]
  21. Pulik M., Teillet-Thiebaud F., Mahe A., Teillet F. Association lymphome non hodgkinien et sclérodermie. Presse Med. 1991 Oct 5;20(31):1513–1514. [PubMed] [Google Scholar]
  22. Roumm A. D., Medsger T. A., Jr Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum. 1985 Dec;28(12):1336–1340. doi: 10.1002/art.1780281204. [DOI] [PubMed] [Google Scholar]
  23. Segel M. C., Campbell W. L., Medsger T. A., Jr, Roumm A. D. Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: Is increased patient screening necessary? Gastroenterology. 1985 Sep;89(3):485–488. doi: 10.1016/0016-5085(85)90440-8. [DOI] [PubMed] [Google Scholar]
  24. Silman A. J. Epidemiology of scleroderma. Ann Rheum Dis. 1991 Nov;50 (Suppl 4):846–853. doi: 10.1136/ard.50.suppl_4.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. TUFFANELLI D. L., WINKELMANN R. K. Systemic scleroderma, A clinical study of 727 cases. Arch Dermatol. 1961 Sep;84:359–371. doi: 10.1001/archderm.1961.01580150005001. [DOI] [PubMed] [Google Scholar]
  26. Talbott J. H., Barrocas M. Progressive systemic sclerosis (PSS) and malignancy, pulmonary and non-pulmonary. Medicine (Baltimore) 1979 Mar;58(2):182–207. doi: 10.1097/00005792-197903000-00006. [DOI] [PubMed] [Google Scholar]
  27. Tielsch J. M., Linet M. S., Szklo M. Acquired disorders affecting the immune system and non-Hodgkin's lymphoma. Prev Med. 1987 Jan;16(1):96–106. doi: 10.1016/0091-7435(87)90009-0. [DOI] [PubMed] [Google Scholar]
  28. Winkelmann R. K., Flach D. B., Unni K. K. Lung cancer and scleroderma. Arch Dermatol Res. 1988;280 (Suppl):S15–S18. [PubMed] [Google Scholar]
  29. ZATUCHNI J., CAMPBELL W. N., ZARAFONETIS C. J. Pulmonary fibrosis and terminal bronchiolar (alveolar-cell) carcinoma in scleroderma. Cancer. 1953 Nov;6(6):1147–1158. doi: 10.1002/1097-0142(195311)6:6<1147::aid-cncr2820060605>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES